IP Library Granted Patent US 9,650,603
Granted Patent B2
US 9,650,603 · App. 14/495,310 · Granted May 16, 2017

Tissue-engineered constructs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,603
App. No.
14/495,310
Granted
May 16, 2017
Kind
B2
Abstract

The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.

Claims (7)

1. A construct comprising a tubular biodegradable non-woven polyglycolic acid scaffold comprising non-biodegradable polyethylene terephthalate supports at each end of the tubular biodegradable polyglycolic acid scaffold, wherein the density of the polyglycolic acid is 45 mg/cc to 75 mg/cc and said density is uniform across the entire tubular scaffold, wherein the thickness of the polyglycolic acid scaffold is 0.8 to 1.2 mm, wherein the polyglycolic acid scaffold comprises polyglycolic acid fibers and the thickness of the polyglycolic acid fibers within the polyglycolic acid scaffold is 5 to 20 μm, wherein the porosity of the polyethylene terephthalate is >200 cc/min/cm 2 and the supports permit the attachment and growth of cells, wherein the length of the tubular biodegradable polyglycolic acid scaffold is at least 10 cm, and wherein the construct is substantially free of heavy metal contaminants.

2. The construct of claim 1 , wherein the length of the tubular biodegradable polyglycolic acid scaffold is 10 cm to 100 cm.

3. The construct of claim 1 , wherein the inner diameter of the tubular biodegradable polyglycolic acid scaffold is 3 mm to 6 mm.

4. The construct of claim 1 , wherein the construct comprises trace amounts of heavy metal contaminants selected from the group consisting of: aluminum, barium, calcium, iodine, lanthanum, magnesium, nickel, potassium and zinc.

5. The construct of claim 1 , wherein the construct further comprises extracellular matrix proteins.

6. The construct of claim 5 , wherein the thickness of the extracellular matrix proteins is greater than 200 micrometers at the thinnest portion of the matrix.

7. The construct of claim 1 , wherein the construct comprises a uniformly entangled seam having a density that matches the overall density of the tubular construct.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 16, 2025
From: HOOK SA LLC, AS PURCHASER AGENT
To: HUMACYTE GLOBAL, INC.
Reel/Frame 073234/0064 →
SECURITY INTEREST Recorded Dec 15, 2025
From: HUMACYTE, INC.; HUMACYTE GLOBAL, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P., AS AGENT
Reel/Frame 073214/0250 →
CHANGE OF NAME Recorded Feb 5, 2025
From: HUMACYTE, INC.
To: HUMACYTE GLOBAL, INC.
Reel/Frame 070121/0235 →
SECURITY INTEREST Recorded May 15, 2023
From: HUMACYTE GLOBAL, INC.
To: HOOK SA LLC, AS PURCHASER AGENT
Reel/Frame 063638/0933 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 033809 FRAME: 0435. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 21, 2019
From: DAHL, SHANNON L.M.; NIKLASON, LAURA E.; STRADER, JUSTIN T.; TENTE, WILLIAM E.; LUNDQUIST, JOSEPH J.
To: HUMACYTE, INC.
Reel/Frame 049557/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2014
From: DAHL, SHANNON L.M.; NIKLASON, LAURA E.; STRADER, JUSTIN T.; TENTE, WILLIAM E.; LUNDQUIST, JOSEPH J.
To: HUMACYTE
Reel/Frame 033809/0435 →